title: Evaluation of osseous metastasis in bone scintigraphy.
abstract: Bone scintigraphy (BS) is an imaging tool commonly used for screening patients with cancer, especially those with high prevalence of osseous metastases including the breast, prostate, lung, thyroid, and kidney, which account for 80% of osseous metastasis. BS has been shown to be of value in the initial and subsequent treatment strategy of various malignancies. The purpose of this article is to evaluate the technical and imaging aspects of BS and to examine the present research into improved detection of osseous metastasis.
authors.affiliation: Russel H. Morgan Department of Radiology and Radiological Sciences, Johns Hopkins University, Baltimore, MD.
authors.forename: Diego
authors.initials: D
authors.lastname: Davila
authors.affiliation: Russel H. Morgan Department of Radiology and Radiological Sciences, Johns Hopkins University, Baltimore, MD
authors.forename: Alexander
authors.initials: A
authors.lastname: Antoniou
authors.affiliation: Russel H. Morgan Department of Radiology and Radiological Sciences, Johns Hopkins University, Baltimore, MD; Tawam Molecular Imaging Center, Al Ain, UAE. Electronic address: mchaudh9@jhmi.edu.
authors.forename: Muhammad A
authors.initials: MA
authors.lastname: Chaudhry
mesh_terms: D001859:Bone Neoplasms / Q000000981:diagnostic imaging* / Q000556:secondary*; D001842:Bone and Bones / Q000000981:diagnostic imaging*; D006801:Humans; D011877:Radionuclide Imaging / Q000379:methods*; D019275:Radiopharmaceuticals
chemical_list: D019275:Radiopharmaceuticals